Search results
Drug CEO: How the industry is fighting to sway impact of Texas abortion pill ruling
Yahoo Finance· 1 year agoThe battle brewing over the Texas abortion pill ruling was not something the drug industry...
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
Simply Wall St. via Yahoo Finance· 3 months agoLast week, Ovid Therapeutics Inc. (NASDAQ:OVID) insiders, who had purchased shares in the previous...
Is Ovid Therapeutics Inc.'s (NASDAQ:OVID) Shareholder Ownership Skewed Towards Insiders?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Ovid Therapeutics Inc. (NASDAQ:OVID) have power over the company....
The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech
Investor's Business Daily· 1 year agoA federal judge's decision in Texas to outlaw a decades-old abortion drug undermines the foundation...
Takeda’s epilepsy drug misses the mark in two Phase III trials
Clinical Trials Arena via Yahoo Finance· 5 days agoTwo Phase III studies of Takeda’s epilepsy drug soticlestat for patients with the rare epilepsies...
How Heat, Panthers ratings compare. And inside TNT’s studio shows, juggling of both teams
Miami Herald via Yahoo News· 1 year agoHow do South Florida’s Heat and Panthers ratings compare during this playoff run, and how do both...
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal via Yahoo Finance· 1 month agoCEO Richard Francis is trying to bring back innovation as part of Teva’s strategy. - dylan...
Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significantly high institutional ownership implies Ovid Therapeutics' stock price is...
Ketanji Brown Jackson Dunks on Alito During Abortion Hearing
The Daily Beast via Yahoo News· 3 months agoReutersU.S. Supreme Court Justice Ketanji Brown Jackson delivered a sizzling retort to fellow...
A new research effort takes aim at 8 rare diseases. It could revolutionize many more.
USA TODAY via Yahoo News· 1 year agoTerry Pirovolakis raised $4.5 million – $20 at a time – to help develop treatments for his son...